| Tillotts Pharma AG - Yaldigo 1600 mg, magensaftresistente Tablette | | 53108 | | 03 | | Yaldigo 1600 mg | | magensaftresistente Tablette | | A07EC02 | | Mesalazine | | 17.07.2019 | | |
| | Composition | | mesalazinum 1600 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 2.268 mg, hypromellosum, silica colloidalis, magnesii stearas, Überzug: hypromellosum, macrogolum 6000, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, triethylis citras, glyceroli monostearas 40-55, polysorbatum 80, kalii dihydrogenophosphas, maydis amylum, E 172, pro compresso obducto. | | Packungsbestandteile | | Gastric juice resistant tablets | | | | | Active Agent | Dose |
|---|
| Mesalazine | 1600 mg |
| | BAG: Active Agent | Dose |
|---|
| Mesalazine | 1600 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acidi Methacrylici | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Glyceroli Monostearas | 40-55 | | | Hypromellosum | | Überzug | | Potassium Dihydrogenophosphate | | | | Macrogol | 6000 | | | Magnesii Stearas | | | | Maydis Amylum | | | | Methylis Methacrylatis Polymerisatum | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | | | Silica Colloidalis | | | | Triethylis Citras | | |
| |
| |
|
